ArticleFrontiers in pharmacology2023

Adebrelimab plus chemotherapy vs. chemotherapy for treatment of extensive-stage small-cell lung cancer from the US and Chinese healthcare sector perspectives: a cost-effectiveness analysis to inform drug pricing.

Yena Gan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.